Ligand Pharmaceuticals
LGND
#4395
Rank
NZ$3.10 B
Marketcap
$169.74
Share price
1.28%
Change (1 day)
60.47%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.54

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.54. In 2022 the company made an earnings per share (EPS) of -$3.20 a decrease over its 2021 EPS that were of $5.59.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.54-179.28%
2022-$3.20-157.23%
2021$5.59-2571.43%
2020-$0.23-100.46%
2019$49.48353.48%
2018$10.911025%
2017$0.97-700%
2016-$0.16-100.87%
2015$18.691859.32%
2014$0.955.36%
2013$0.918.0704505322479E+18%
2012$0.0000000000-100%
2011$0.79-194.23%
2010-$0.84548.38%
2009-$0.13-98.7%
2008-$9.99-136.52%
2007$27.35-787.8%
2006-$3.98-14.58%
2005-$4.66-21.31%
2004-$5.92-55.15%
2003-$13.1981.33%
2002-$7.272.74%
2001-$7.08-45.93%
2000-$13.09-14.56%
1999-$15.32-45.52%
1998-$28.12-3.97%
1997-$29.29132.31%
1996-$12.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.87 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.58-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.66 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.94 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.01 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.78 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.42 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.28 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.77 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA